Search

everythinglearnresearchcommunity

for

Search:↓

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Moderately high prolactin levels do not cause hair loss in women.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Hydroxychloroquine may help treat alopecia areata in children.

The document concludes that more research is needed to fully understand the causes of PCOS.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

More than half of patients who had acromegaly surgery experienced hair loss, with varying degrees of recovery.

Hirsutism causes significant psychological distress in women.

Early treatment of PCOS is crucial for better health and quality of life.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.